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Exposure  to urban  air pollution  has  been  associated  with  adverse  effects  on  cardio-vascular  and  respi-
ratory  health,  both  short  and  long  term.  Consequently,  governments  have  applied  policies  to  reduce  air
pollution.  Quantitative  health  impact  assessments  of  hypothetic  changes  in air pollution  have  been  con-
ducted  at  national  and  global  level,  but assessments  of observed  air pollution  changes  associated  with
speciﬁc  clean  air policies  at  a local  or regional  scale  remain  scarce.  This  study  estimates  health  impacts
attributable  to a decrease  in  PM10 and  NO2 exposure  in  the  Agglomeration  of Lausanne-Morges  (ALM),
Switzerland,  between  2005  and  2015,  corresponding  to  the  implementation  period  of  a supra-municipal
plan  of  measures  to  reduce  air pollution  in  different  sectors  such  as  transport,  energy,  and industry  (called
Plan OPair  05).  The  health  impact  assessment  compares  health  effects  attributed  to  air pollution  exposure
levels  in  2015  (reference  case)  with those  in  2005  (counterfactual  scenario),  using 2015  as  baseline  for
all  other  input  data.
In  the  ALM,  the  modeled  PM10 exposure  reduction  of 3.3  g/m3 from  2005  to  2015  prevents  26  prema-
ture  deaths  (equivalent  to around  290  years  of  life  lost),  215  hospitalization  days  due  to  cardio-vascular
and  respiratory  diseases  as well  as approximately  47,000  restricted  activity  days  annually.  Monetized
health  impacts  of the reduction  of PM10 exposure  are  valued  at approximately  CHF 36  million  annually.
Immaterial  costs,  mainly  related  to the  economic  valuation  of  years  of  life  lost,  dominate  the  monetized
health  impacts  (90%  of total  value),  while  savings  at the  workplace  (net loss  in production  and  reoccu-
pation  costs)  amount  to about  CHF  1.9  million,  and  savings  in health  care  costs  to about  CHF  0.5 million.
The  assessment  is  sensitive  to the  value  assigned  to  immaterial  costs  and  to  uncertainties  in  the  rela-
tive  risk  estimates,  whereas  variations  in  the  baseline  year  (i.e. using  2005  data  instead  of  2015  data)
affect  results  to a much  lower  degree.  The  alternative  calculation  based  on  NO2 exposure,  which  dropped
by 5.6  g/m3, suggests  the  prevention  of 51  premature  deaths  (equivalent  to  around  550  years  of  life
lost)  overall  impacts  valued  at CHF  49 million.  All  in  all, the reduction  in  mortality  due  to  the  air  quality
improvements  accounts  for  (depending  on  the  considered  pollutant)  about  1% to 2% of total  all-cause
annual  mortality  in  the ALM  population  or 4–8  times  larger  than  the  annual  trafﬁc  fatalities  in the  ALM.
© 2017  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Ambient air pollution is a well-known cause of a broad range
of morbidities and premature mortality (Künzli et al., 2010; WHO,
2013a). Adverse health effects of poor air quality are of particular
relevance in urban areas since density of both exposed popula-
tions and pollution sources is higher. To protect public health, WHO
proposes science based guideline values as the target for clean
∗ Corresponding author.
E-mail addresses: alberto.castrofernandez@uzh.ch (A. Castro),
nino.kuenzli@unibas.ch (N. Künzli), thomas.goetschi@uzh.ch (T. Götschi).
air policies (WHO, 2005). Although very few countries adopted
those values as national standards (Künzli et al., 2015) many gov-
ernments worldwide have implemented clean air policies and
strategies to successfully reduce ambient air pollution at different
scales (Brauer et al., 2016).
For policy makers and the public it is of major relevance to
understand the overall impact and costs of air pollution related
health effects. In 1996, the Swiss Government was the ﬁrst to ask
scientists about the health impact and costs of trafﬁc related air
pollution in Switzerland (Künzli et al., 1997) neighboring France
and Austria (Künzli et al., 2000). The methods developed for these
studies were soon applied also on a global scale as part of the Global
Burden of Disease (Cohen et al., 2005) and an increasing number
http://dx.doi.org/10.1016/j.ijheh.2017.03.012
1438-4639/© 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Fig. 1. ALM borders and municipalities involved in the application of the Plan OPair 05 (highways are represented in orange, major roads in yellow, green areas in green and
the  lake Geneva in blue) (Muller, 2016a). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web  version of this article.)
of studies have since then assessed air pollution impacts on the
local, regional or national scale. Some responded to speciﬁc clean
air policy scenario questions (e.g. Silveira et al., 2016) or city spe-
ciﬁc conditions (e.g. Ballester et al., 2008) or sources (e.g. Perez
et al., 2013). The Swiss Government asked for repeated updates
of these assessments with the last one referring to the air qual-
ity achieved in 2010 (ECOPLAN and INFRAS, 2014; Vienneau et al.,
2015). Whereas national or international assessments are very use-
ful in the national policy making discussions, those studies are less
informative on the local scale of cities. However, cities are usually
responsible for the local implementation of clean air policies, thus,
may  need to demonstrate the local health beneﬁts of sometimes
hotly debated local strategies.
The Ordinance on Air Pollution Control (OPair in French; Ordon-
nance sur la Protection de l’AIR) regulated in Switzerland in 1985
emissions, requirements of fuels, maximum permitted pollution
levels and procedures in case of excessive levels (Swiss Federal
Council, 1985). In the Agglomeration Lausanne-Morges (ALM),
located in the Swiss Canton of Vaud, to apply the above mentioned
national ordinance and to boost the reduction of air pollution initi-
ated after previous municipal actions, the so called Plan of Measures
OPair 2005 (from now on referred to as Plan OPair 05) was  addition-
ally implemented from 2005 to 2015 (Vaud, 2005). The Plan OPair
05 suggested ﬁfty speciﬁc measures across different sectors such
as mobility, transport of goods, energy production, industry and
household energy consumption (Vaud, 2005) to reduce pollution
in the 24 municipalities of the ALM (Fig. 1). The ALM had in 2015
around 293,000 inhabitants and a mortality rate of 337 deaths per
100,000 inhabitants (Table 1).
The goal of the present study, committed by the Canton of Vaud,
was to estimate and monetize the health impacts associated with
Table 1
Key ﬁgures of the Agglomeration Lausanne-Morges.
Agglomeration Lausanne-Morges
Feature Value Source
Number of municipalities 24 Vaud (2005)
Area 135 km2 Muller (2016a)
Population in 2005 254,914 inhabitants Oettli et al. (2016a)
Population in 2015 293,100 inhabitants Oettli et al. (2016a)
All-cause mortality rate in
2015
739 deaths per 100,000
inhabitants
Oettli et al. (2016b)
Life expectancy at birth in
2012–2015
81 years for male, 85 for
women
Oettli et al. (2016b)
the reduction of particular matter smaller than 10 g (PM10) and
nitrogen dioxin (NO2) exposure in the ALM from 2005 to 2015, i.e.
the implementation phase of the Plan OPair 05. A sensitivity anal-
ysis was additionally performed regarding uncertainty in health
effects, immaterial cost estimates, and choice of baseline year.
To enhance comparability of the local ALM results with national
assessments, methods were fully lined up with those used in the
recent Swiss assessment (Vienneau et al., 2015). The speciﬁc steps
of the calculations are described in the following sections. Method-
ology and results are explained in more detail in the Supplementary
materials.
2. Materials and methods
2.1. General approach
As Fig. 2 shows air pollution decreased gradually in the ALM
from 2005 to 2015 (Muller, 2016b). Applying a comparative risk
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Fig. 2. Mean measured concentration of PM10 from three monitoring stations and
NO2 from 150 passive sampler locations in ALM in 2005, 2010 and 2015 (NO2 mea-
surements only available for these years between 2005 and 2015) (based on data
from Muller, 2016b).
Fig. 3. Schematic representation of risk assessment comparing reference case and
the counterfactual scenario.
assessment (WHO, 2016a), this study compares a reference case
with an alternative − counterfactual − scenario (Fig. 3). The refer-
ence case is set in 2015 (end of the Plan OPair 05) using the actual
status-quo in the ALM in terms of air pollution, population demo-
graphics, and disease rates. In contrast, the counterfactual scenario
assumes that air pollution exposure did not change since 2005
(launch of the plan), i.e. uses exposure data from 2005, but oth-
erwise uses the same population and health data from 2015 as the
reference case. The associated health impacts were estimated as
the difference between the impacts in the reference case and the
counterfactual scenario. Thus, impacts are only calculated for one
year, i.e. for 2015, what provides reasonable estimates also for the
health impacts to be expected in the following years (assuming no
changes in air pollution compared to 2015).
Fig. 4 shows a simpliﬁed workﬂow of the present study.
Observed air pollution exposure levels, empirical relative risks,
baseline health rates and population data were combined to
estimate mortality and morbidity impacts. These impacts were
monetized applying costs per health outcome unit.
Health outcomes considered were selected based on availabil-
ity of concentration-response functions meta-analyzed from the
peer-reviewed literature (Vienneau et al., 2015; WHO, 2013a) and
included those listed in Table 2. Furthermore, all-cause (natural)
mortality attributed to air pollution in post-neonatal (<1 years old)
and adult population (≥30 years old) was estimated using three
different measures; namely (all-age) premature deaths, years of
life lost, and years of working life lost. Mortality impacts on peo-
ple between 1 and 29 years old were not considered in this study
due to the lack of epidemiologic evidence (key studies providing
concentration-response functions did not included this age group).
The calculations were based on the methodology developed as
part of the estimation of Swiss transport externalities (ECOPLAN
and INFRAS, 2014) and expanded to include two markers of ambi-
ent air pollution, namely PM10 and NO2 exposure, a strategy now
approved by WHO  (Héroux et al., 2015). The impacts of PM10 and
NO2 exposure are not intended to be aggregated, since these pollu-
tants correlate in space and time, share a range of sources, and serve
as partly overlapping markers of the same health effects (WHO,
2013a, p. 12WHO, 2013aWHO, 2013a, p. 12). Rather they serve
as complementary estimates to gauge differences with regard to
selected pollution indicators.
Details on the methods and all equations are provided in a Sup-
plementary material.
2.2. Data
Exposure and population data from 2005 and 2015 for ALM
were provided by the Canton of Vaud on a spatial resolution
of 100 × 100 m (Muller, 2016c). PM10 exposure estimates were
produced by a dispersion model that used the detailed emis-
sions inventory of the Canton of Vaud (called CADERO) based
on three monitoring stations, while NO2 estimates were derived
from approximately 150 measurement sites (passive sampling).
The differences in population-weighted exposures between 2005
and 2015 were 3.3 g/m3 for PM10 and 5.6 g/m3 for NO2.
The World Health Organization (WHO), as part of the project
Health Risks of Air Pollution In Europe (HRAPIE), carried out a broad
literature review and meta-analysis of international studies and air
pollution epidemiology databases (APED) concerning the effects
of PM,  NO2 and ozone (O3), and provided recommendations on
the corresponding relative risks for health impact assessments
(WHO, 2013a). This study used relative risks recommended by
WHO  (2013a) and added an additional one from a meta-analysis of
a more recent Swiss publication that provided the missing relative
risk for asthma in adults (ECOPLAN and INFRAS, 2014). A log-linear
concentration response relationship for both pollutants and all out-
comes was  assumed. Accordingly, relative risks were scaled to the
local exposure applying a log-linear scaling function, thus, the per-
cent increase per unit increase in pollution remains stable. Table 2
shows the list of relative risks and sources that were considered in
this study.
Baseline mortality and morbidity rates used are presented in
Table 3. Concerning mortality, two data sets were obtained for the
ALM: (1) life tables (i.e. probability of dying) and (2) number of
deaths by cause (i.e. natural and non-natural), both by one-year
age group and gender. Probability of dying from all causes was
derived from life tables for the period 2012–2015, while the share
of natural deaths (i.e. excluding accidental and violent deaths) was
based on averages from 2002 to 2014. Baseline morbidity rates
were collected from several sources. Data on hospitalizations in
2015were provided by the Canton of Vaud and covered regions for
medical statistics (MedStat), which slightly exceed the ALM area
(Stadelmann, 2016a). For the remaining health outcomes, i.e. inci-
dence and prevalence of bronchitis and asthma among children and
adults as well as restricted activity days and working days lost, rates
were adopted from Swiss and international studies previously used
by Vienneau et al. (2015) and ECOPLAN & INFRAS (2014).
Population data as well as data regarding employed popula-
tion in the ALM stratiﬁed by one-year age groups and gender
were obtained from the Statistical Ofﬁce of the Canton of Vaud
(Oettli et al., 2016a). The data were aggregated as needed to match
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Fig. 4. Simpliﬁed workﬂow of the health impact calculation.
Table 2
Relative risk (RR) estimates and their 95% conﬁdence interval (CI) as applied in the estimation of impacts.
PM10 NO2
Health outcome Age group applied to RR per 10 g/m3 (95%
CI)
Source RR per 10 g/m3 (95%
CI)
Source
Mortality (all cause,
natural)
≥30 Years old 1.045
(1.029–1.060)f
WHO  (2013a) based on
a meta-analysis of 13
studies from Hoek et al.
(2013)
1.055
(1.031–1.080)
WHO  (2013a) based on
a meta-analysis of 11
studies from Hoek et al.
(2013)
Post-neonatal infant
mortality (all cause,
natural)
0–1 Years old 1.040
(1.020–1.070)
WHO  (2013a) based on
Woodruff et al. (1997)
Hospital admissions for
CVD (including stroke)
All ages 1.007
(1.001–1.012)f
WHO  (2013a) based on
own APED
meta-analysis of 5
studies
Hospital admissions for
RD
All ages 1.014
(0.999–1.029)f
WHO  (2013a) based on
own APED
meta-analysis of 3
studies
1.018
(1.012–1.025)
WHO  (2013a) based on
own APED
meta-analysis of 15
studies
Incidence of chronic
bronchitis in adults
≥18 Years old 1.117
(1.040–1.189)
WHO  (2013a) based on
a combination of 2
studies
Prevalence of
bronchitis in children
5–17 Years old a 1.080
(0.980–1.190)
WHO  (2013a) based on
Hoek et al. (2012)
Asthma attacks in
adults with asthma
≥18 Years old b 1.029
(1.013–1.045)
Vienneau et al. (2015)
based on a
meta-analysis of 6
studies carried out by
ARE (2004)
Days with asthma
symptoms in asthmatic
children
5–17 Years old c 1.028
(1.006–1.051)
WHO  (2013a) based on
a meta-analysis of 36
studies from
Weinmayr et al. (2010)
Restricted activity days ≥18 Years old d 1.034
(1.030, 1.038)f
WHO(2013a) based on
Ostro (1987)
Work days lost >15 Years old
(employed persons)e
1.033
(1.028, 1.038)f
WHO(2013a) based on
Ostro (1987)
a Original age group of the PM10 relative risk: 6–12 (now applied to 5–17).
b Original age group of the PM10 relative risk: >14 (now applied to 5–17).
c Original age group of the PM10 relative risk: 5–19 (now applied to 5–17).
d Original age group of the PM10 relative risk: all ages (now applied to ≥18).
e Original age group of the PM10 relative risk:20–65 (now applied to >15).
f The original relative risk was  converted from PM2.5 to PM10 using a log-linear conversion function.
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Table  3
Baseline health rates applied in the estimation of impacts.
Health outcome Age group Baseline health rates for general
population
Source
Mortality (all cause,
natural)
≥30 Years old Probability of dying by one-year
age group and gender extracted
from the life table for the period
2012–2015 in the ALM; share of
non-natural deaths by one-year
age group and gender for the
period 2002–2014 in the ALM
Dataset on vital statistics from the
Statistical Ofﬁce of the Canton of
Vaud (Oettli et al., 2016b)
Post-neonatal infant
mortality (all cause,
natural)
<1 Year old Probability of dying by one-year
age group and gender extracted
from the life table for the period
2012–2015 in the ALM MedStat
regions
Dataset on vital statistics from the
Statistical Ofﬁce of the Canton of
Vaud (Oettli et al., 2016b)
Hospital admissions for
CVD (including stroke)
All ages 1.21 admissions and 16.46 days of
hospitalization per 100 inhabitants
in 2015 in the ALM MedStat
regions (data from patients living
in the ALM Med-Stat regions that
are treated in hospitals of the
Canton of Vaud)
ICD-10 I00-I99 hospitalization data
collected by the Swiss Federal
Statistical Ofﬁce and provided by
the Statistical Ofﬁce of Canton of
Vaud (Stadelmann, 2016b)
Hospital admissions for RD All ages 1.00 admission and 7.40 days of
hospitalization per 100 inhabitants
in 2015 in the ALM MedStat
regions (data from patients living
in the ALM Med-Stat regions that
are treated in hospitals of the
Canton of Vaud)
ICD-10 J00-J99 hospitalizations
from the database of the Statistical
Ofﬁce of Canton of Vaud
(Stadelmann, 2016b)
Incidence of chronic
bronchitis in adults
≥18 Years old 0.39 cases per 100 adults and year Vienneau et al. (2015) based on
Swiss study SAPALDIA (Schindler
et al., 2009)
Prevalence of bronchitis in
children
5–17 Years old a 18.6 cases per 100 children and
year
Vienneau et al. (2015) based on the
PATY study in six countries
including Switzerland (Hoek et al.,
2012)
Asthma attacks in adults
with asthma
≥18 Years old 21 attacks per 100 adults and year
(based on 3.9 yearly asthma
attacks per asthmatic adult and 5.4
asthmatics per inhabitant)
ECOPLAN & INFRAS (2014) based
on the European Community
Respiratory Health Survey (Burney
et al., 1996)
Days with asthma
symptoms in asthmatic
children
5–17 Years old b 304 symptom days per 100
children and year (based on
prevalence of 4.9% of severe
asthma in children and daily
incidence of 17% of symptoms in
children with asthma)
Vienneau et al. (2015) based on the
international study ISAAC (Lai
et al., 2009)
Restricted activity days ≥18 Years old 1900 days per 100 adults per year Vienneau et al. (2015) based on
Ostro (1987)
Working days lost ≥15 Years old (employed persons) 720 days per 100 employed
persons and year
ECOPLAN & INFRAS (2014) based
on HEIMTSA (2010)
a The original source refers to children at the age group 6–18 (now applied to 5–17).
b The original source refers to children at the age group 5–19 (now applied to 5–17).
the corresponding age groups used for the morbidity and some
mortality-related calculations (see age groups in Table 3). Popula-
tion data were from 2015, while employment ﬁgures were averages
for the period 2010–2014.
Costs per outcome unit were used from a previous study, which
was committed by the Federal Ofﬁce of Spatial Planning (ARE in
German) and estimated external costs of transport in Switzerland
(ECOPLAN and INFRAS, 2014; pp. 140–148). Figures from 2010 were
adjusted to 2015 applying the average inﬂation rate in Switzerland
in this period (−2.7% since 2005; −2.5% for health care costs) (FSO,
2016).
2.3. Estimation of health impacts
Impacts of air pollution were quantiﬁed by calculating popu-
lation attributable fractions (PAF), which quantify the fraction of
all cases of a speciﬁc outcome that can be attributed to a certain
exposure − in this case air pollution (Zapata-Diomedi et al., 2016).
PAF is a function of the relative risk and the population at risk.
This study assumes that 100% of the population is exposed popu-
lation. Health impact assessment estimates PAFs based on the air
pollution levels of the reference and the counterfactual scenario
and quantiﬁes the difference in attributable cases. Separate PAFs
were calculated for the strata deﬁned by outcome (mortality and
various morbidities), pollutant (PM10 or NO2), pollution level (ref-
erence or counterfactual), and age groups. These PAFs were applied
to the outcome calculations based on population and background
health data.
Mortality impacts were estimated applying a life table method
(Miller and Hurley, 2003; Röösli et al., 2005) following ECOPLAN &
INFRAS (2014) and Vienneau et al. (2015). Life tables allow accurate
calculations of years of life lost by taking into account the different
life expectancies at different ages, e.g. 81 years among men  and 85
years among women  born in the ALM in 2012–2015 (Oettli et al.,
2016b). Probability of dying due to natural causes was calculated by
age-year and for each year from 2015 till one hundred years into the
future, based on current population and mortality data. Based on
this, years of life lost due to natural causes were quantiﬁed. Under
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Table 4
Annual prevented health impacts due to the reduction of exposure to PM10 and NO2 in the ALM from 2005 to 2015.
Health outcome PM10 NO2 Unit
Premature deathsa 26 51c,d Deaths
Years  of life lost (<1 & ≥30 years old)a 289 546c,d Years of life
Years  of working life lost (<1 & ≥30 years old)a 34 55c,d Years of working life
Hospitalization days due to CVD (all ages) 103 Hospitalization days
Hospitalization days due to RD (all ages) 112 244d Hospitalization days
Incidence of chronic bronchitis in adults (≥18 years old) 27 Cases
Prevalence of bronchitis in children (5–17 years old) 149 Cases
Asthma  attacks in adults with asthma (≥18 years old) 447 Attacks
Days  with asthma symptoms in asthmatic children (5–17 years old) 970 Symptom days
Restricted activity days (≥18 years old)b 46,903 Days
Working days lost (≥15 years old, employed persons)b 10,986 Days
a Premature deaths, years of life lost and years of working of life lost are overlapping indicators and therefore non-additive with each other when monetizing, i.e. only one
of  the monetized impacts should be considered depending on the cost category of interest (see Table 5).
b Restricted activity days and working days lost are overlapping indicators and therefore non-additive with each other when monetizing, i.e. only one of the monetized
impacts  should be considered depending on the cost category of interest (see Table 5).
c Not including infants (i.e. persons aged <1 years old) due to lack of applicable relative risk.
d PM10 and NO2 health impacts should not be aggregated since they might overlap (see General Approach in Section Materials and Methods).
the reference case, these were multiplied by the PAF for air pollu-
tion levels in 2015 to derive years of life lost attributable to 2015 air
pollution levels. Under the counterfactual scenario, the same was
done with the PAF for air pollution levels in 2005. Annual years of
life lost attributable to the reduction in air pollution between 2005
and 2015 are the difference in years of life lost attributable to air
pollution 2015 and 2005. Attributable years of life lost were aggre-
gated for ages 30 and older, and postnatal deaths. Years of working
life lost were calculated by applying the share of employed popu-
lation to ages 15 and older (including employed population above
usual retirement age, i.e. 65 for men  and 64 for women). This again
was done by one-year age group and year (from 2015 till one hun-
dred years into the future) to the previously obtained years of life
lost.
Morbidity impacts attributable to air pollution were calculated
following the same approach, applying PAFs to baseline disease
rates for the reference and counterfactual scenario, and then calcu-
lating the difference in attributable cases.
2.4. Monetization
Costs were classiﬁed into four categories, namely medical costs
(costs for hospital treatments of air pollution related diseases), net
loss in production (cost for employers when reducing yields due to
absenteeism among air pollution exposed employees), reoccupa-
tion costs (costs for employers replacing employees due to health
impacts of air pollution) and immaterial costs. Immaterial costs
are based on Value of a Statistical Life (VSL), which represents the
value a given population places ex ante on avoiding the death of
an unidentiﬁed individual (OECD, 2012). VSL is based on studies
that request individual’s willingness to pay for small reductions
in mortality risk, which are then extrapolated to reﬂect the value
of reducing risk to save one life. Conceptually, willingness to pay
also includes the share of health costs paid directly by the victims
and lost consumption, in addition to immaterial costs (ECOPLAN
and INFRAS, 2014; p. 141). This study used a VSL value of CHF 3.3
million updating the value of a previous national Swiss report on
external effects of transport (ECOPLAN and INFRAS, 2014; p. 146).
In order to monetize health impacts, costs per health outcome
unit were multiplied by the estimated number of corresponding
outcomes. When assessing total costs, not all outcomes must be
added up to avoid double counting of impacts for which there are
more than one overlapping indicator. Therefore, this study only
monetized one outcome per cost category (i.e. immaterial costs
of years of life lost were considered but not of premature deaths;
production costs of years of working life lost were considered but
not all years of life lost; immaterial costs of restricted activity days
were considered but no production costs of working days lost; see
Table 5). Costs due to hospitalizations as well as asthma and bron-
chitis were subtracted from costs attributed to restricted activity
days and working days lost.
The value of future years of life was  discounted according to
economic approaches suggesting that future values are worth less
than present values. An annual discount rate of 2% and growth rate
of 1% was  applied according to the Swiss Norm for Cost-beneﬁt
Analysis in Road Transport (SN 641 821).
2.5. Sensitivity analysis
A sensitivity analysis was  carried out to assess the inﬂuence of
two key input data: (a) relative risks and (b) immaterial cost value
applied to health outcomes. For relative risks, lower and upper
bounds of the 95% conﬁdence intervals were used (WHO,  2013a),
while for immaterial relative cost of health outcomes values 50%
lower and 100% higher were applied following ARE (2004, p. 75).
Additionally, the baseline year for the reference case and coun-
terfactual scenario was  shifted from 2015 to 2005 to assess the
sensitivity of results towards changes in population and baseline
health data.
3. Results
3.1. Health impacts
Table 4 shows the estimated health impacts for one year (2015)
that were prevented in the ALM as a result of the reduction in air
pollution exposure of 3.3 g/m3 PM10 and 5.6 g/m3 NO2, within
the period of the Plan OPair 05, i.e. 2005–2015. According to this
estimation, the reduction of exposure to PM10 prevented 26 pre-
mature deaths (equivalent to around 290 years of life lost including
30 years of working life lost) among infants below 1 year old and
adults age 30 and older. Furthermore, approximately 100 hospital-
ization days due to CVD and 110 due to RD, respectively, 30 incident
cases of bronchitis and 450 asthma attacks in adults and about 150
prevalent cases of bronchitis and 1,000 asthma symptom days in
children were prevented. Finally, around 47,000 restricted activity
days were prevented, including around 11,000 working days lost.
Assessments based on NO2 resulted in approximately two times
larger attributable burdens (years of life lost, years of working life
lost and hospitalization days due to RD). NO2 mortality outcomes do
not include infants younger than one year old because no applicable
relative risk for all cause mortality was  available.
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Fig. 5. Sensitivity analyses of total prevented costs for the reduction of PM10 and NO2 exposure in the ALM from 2005 to 2015 when varying relative risks (RRs) between low
and  high 95% conﬁdence interval values and immaterial costs between low and high estimates.
3.2. Monetized value of health impacts
The result of monetizing the above health impacts are shown
in Table 5. The reduction in air pollution between 2005 and 2015
results in annual beneﬁts valued at CHF 36 million (PM10) to CHF 49
million (NO2) in the ALM. Immaterial costs make up for 94% of these
beneﬁts (CHF 34 and 46 million for PM10 and NO2, respectively).
Medical cost savings amount to around CHF 0.5 million for PM10 or
CHF 0.2 million for NO2. Work-related cost savings (net loss in pro-
duction and reoccupation costs) are in the range of CHF 1.9 millions
for PM10 or CHF 2.5 million for NO2. Premature deaths were not
monetized because they are contained in the years of life lost. Net
loss in production was estimated using working days lost, while
immaterial costs were estimated using restricted activity days to
avoid double counting of overlapping indicators (see Materials and
Methods and Table 4).
3.3. Sensitivity analysis
The sensitivity of monetized health impact estimations to vari-
ability of relative risks and immaterial cost was analyzed (Fig. 5).
In the calculations based on the lower bound (95% CI value of rela-
tive risks and the low immaterial cost estimate per outcome unit)
total prevented costs of reducing pollution in the ALM from 2005
to 2015 were around CHF 18 million in terms of PM10 exposure
or CHF 16 million in terms of NO2 exposure. Using instead the
higher bound (CI value of relative risks and high immaterial cost
estimates), prevented costs reach CHF 75 million when considering
PM10 difference of exposure or CHF 128 million when considering
NO2. When exclusively varying relative risk values (ﬁxed medium
value of immaterial cost) in PM10 exposure, total prevented costs
range from about CHF 26 million (27% lower than the medium
bound) to about CHF 45 million (24% higher). In contrast, when
varying immaterial cost per health outcome unit and ﬁxing rela-
tive risk, total prevented cost of the reduction of PM10 exposure
range from about CHF 24 million (33% lower) to CHF 60 million
(66% higher).
When using population and baseline health data from 2005
instead of 2015, the estimation of mortality impacts in terms of
prevented years of life lost and years of working life lost is 1% and
5% higher respectively, while the number of prevented premature
deaths is 1% lower.
4. Discussion
This study has found that in the ALM the prevention of 26 pre-
mature deaths per year can be attributed to the reduction of PM10
exposure by 3.3 g/m3, as achieved during the 10-year period of the
Plan Opair 05 (i.e. from 2005 to 2015). The estimates based on NO2
exposure, which was  reduced by 5.6 g/m3 since 2005, are about
twice as high. The reduction in premature deaths due to these air
quality improvements is equivalent to about 1% to 2% of the total
all-cause annual mortality in the ALM and about 4–8 times larger
than all annual trafﬁc fatalities in the ALM (Martin and Oettli, 2016).
Moreover, the reduction of years of life lost is equivalent to about 5%
to 10% of years of life lost of ALM population younger than 70 years
old (assuming that this is the average life expectancy of all-age
ALM population within the period 2005–2015) (Pasche and Oettli,
2016). The value of health impacts prevented every year amounts
to CHF 36 million and CHF 49 million, or about CHF 120 to CHF 170
per ALM inhabitant, for PM10 or NO2, respectively. These ﬁndings
are somewhat sensitive with regards to uncertainty in relative risks
(−24% to +27%) and the value assigned to immaterial costs (−33% to
+66%). Choice of baseline year (2005 instead of 2015) for population
and health data had little inﬂuence on the results.
This is one of only few studies that valued health impacts of
speciﬁc clean air policies on such local level. For instance, Künzli
et al. (2000) attributed 6% of total mortality in Switzerland (around
8 million inhabitants) for a counterfactual air pollution contrast
of 14 g/m3 PM10. In a more recent assessment in Switzerland
Vienneau et al. (2015) attributed 14,000 years of life lost and 8,700
hospital days due to CVD every year to air pollution from trans-
port alone (contrast of 19.4 g/m3 PM10). For the metropolitan area
of Barcelona with about 3.8 million inhabitants, about ten times
more than in the ALM, Perez et al. (2008) estimated that reduc-
ing PM10 concentrations by 30 g/m3 would prevent 3,500 deaths
and 1,800 CVD hospitalizations annually. The recently completed
ESCAPE project (Beelen et al., 2014) has conﬁrmed, for the ﬁrst time
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Table 5
Monetization (in CHF millions) of medical costs (MC), net losses in production (NLP), reoccupation costs (RC) and immaterial costs (IC) of health impacts attributed to the
reduction in air pollution (2005–2015).
Cost saving (in CHF million)
PM10 NO2
Health outcome (applied age group) MC NLP RC IC Total MC NLP RC IC Total
Years of life lost (<1 & ≥30 years old, discounted) 24.058 24.058 46.000 46.000
Years  of working life lost (<1 & ≥30 years old, discounted) 0.426 1.023 1.448 0.729 1.751 2.480
Hospitalization days due to CVD (all ages) 0.153 0.006 0.081 0.240
Hospitalization days due to RD (all ages) 0.112 0.008 0.088 0.208 0.245 0.017 0.191 0.453
Incidence of chronic bronchitis in adults (≥18 years old) 0.180 0.006 2.901 3.087
Prevalence of bronchitis in children (5–17 years old) 0.008 0.000 0.043 0.052
Asthma attacks in adults with asthma (≥18 years old) 0.000 0.007 0.031 0.038
Days with asthma symptoms in asthmatic children (5–17 years old) 0.001 0.003 0.067 0.070
Restricted activity days (≥18 years old) 6.595a 6.595
Working days lost (≥15 years old, employed persons) 0.401 a 0.401
Total 0.454 0.856 1.023 33.866 36.198 0.245 0.746 1.751 46.191 48.933
a Costs for hospitalization, bronchitis and asthma have been subtracted from restricted activity days and work days lost.
in Europe, that there is no lower “threshold of no effect” of ambi-
ent air pollution on mortality, providing a clear rationale to further
improve air quality, and to quantify the beneﬁts of such improve-
ments, even at relatively low levels of pollution, as seen in the ALM.
Swiss data also contributed to ESCAPE. Given this evidence, fur-
ther reductions of air pollution will continue to result in the same
additional and sustainable beneﬁts − every year.
This study relies on several assumptions and has some limita-
tions (explained below) that should be taken into account when
interpreting the results.
The study considers two air pollution indicators, PM10 and NO2.
PM10 is generally considered an indicator of background and sec-
ondary pollution originated from both local and remote sources
(Perez et al., 2008; Wang et al., 2006). Thus, spatial variation is
rather limited and reliable estimates of exposure can be derived
from a few stations, such as the three monitors used to inform the
ALM model. Local policies may  have only limited effects on PM10
given the long-range transboundary travel of these pollutants. NO2
concentrations, on the other hand, are less homogeneously dis-
tributed in space. If measured at many sites, as done in the ALM, NO2
more accurately captures variations in local combustion sources,
such as trafﬁc, which is a primary target of the measure of the
Plan Opair 05. When assessing the impacts of local policies, the
use of a trafﬁc-sensitive pollution indicator, like NO2, is there-
fore particularly appealing. In its aim to provide a comprehensive
assessment of health impacts of air pollution reductions, this study
therefore used both, PM10 and NO2 as complementary indicators.
This implies, however, that where available for the same outcome,
impacts should not be added up, as they may  largely overlap. To
date, so called 2-pollutant models are inconclusive with regards to
quantifying the independent effects of each marker of pollution,
and the degree of overlap of correlated indicators (WHO, 2013a,
2014a). However, the epidemiologic literature on health effects
of NO2 is still less exhaustive, lacking risk estimations for sev-
eral outcomes that have been associated with particulate matter
(see Table 2). Moreover, to guarantee comparability with the last
estimation of Swiss transport externalities (ECOPLAN and INFRAS,
2014), this study also abstained from adding outcomes not previ-
ously considered in PM based assessments. For instance, we  have
not added asthma onset as a consequence of exposure to NO2
although a recent study provided meta-analytic evidence for this
outcome (Khreis et al., 2017). Thus, the overall impact of the NO2-
based assessment covers only a subset of the PM-related impact.
The substantially higher impacts for NO2 – among outcomes
assessed for both markers − probably reﬂect either a chance ﬁnd-
ing (given the substantial overlap in the ranges of uncertainties) or
a combination of the more pronounced relative reduction in NO2
concentrations (presumably as a result of targeted OPair 05 poli-
cies) and/or stronger toxicological effects associated with NO2 or
its correlates, namely trafﬁc exhaust. Additionally, uncertainties in
exposure assessment both in the local air pollution model, as well
as in the underlying epidemiologic studies may  have contributed to
the differences between the two pollution indicators. It should also
be noted that total impacts for NO2 would have been even higher if
additional relative risks would be available. Future NO2 based risk
assessments may  include other health outcomes.
This assessment did not include O3 and SO2 although it is well
known that ambient exposure to pollutants marked with these
gases causes additional health problems (WHO,  2013a; Nafstad
et al., 2003) that occur independently of those attributed to PM or
NO2. A report of the U.S. Academies of Sciences agreed with impact
assessment strategies that add O3 impacts to those quantiﬁed for
PM (NRC, 2008) and indeed, the Global Burden of Disease studies
(Brauer et al., 2016) provide estimates for both, PM2.5 and O3. How-
ever, as compared to the overall effects associated with PM,  the O3
associated burden is negligible, particularly in cities where O3 levels
tend to be lower due to the scavenging of O3 by primary pollutants
such as trafﬁc emissions. Moreover, although O3 concentrations
showed downward trends in Switzerland, these changes were less
strong and more relevant in rural areas. O3 is also a regional phe-
nomenon, thus, local policies such as those implemented by the
Plan OPair 05 have only a limited impact on O3 in the ALM. Further-
more, it could be of interest to use PM2.5 as an alternative measure.
However, such concentration data are currently not available for
the ALM. Neglecting SO2 related effects is also expected to be irrel-
evant in this Swiss study given that SO2 concentrations got reduced
to very low levels until the end of the last century, thus, changes
during the last decade were very minor (INFRAS and Meteotest,
2013).
All concentration-response functions used in this assessment
rely on multivariate adjusted estimations of the contribution of
air pollution to the various outcomes. However, the relative risk
estimates used in this assessment still have different levels of
uncertainty, as emphasized in the investigations and guidelines
of the WHO  projects REVIHAP (WHO, 2013b) and HRAPIE (WHO,
2013a). For example, there is a very strong and broad evidence
for air pollution effects on mortality and life expectancy, including
meta-analytic effects (i.e. relative risks) partly based on Swiss data
(Beelen et al., 2014). In contrast, estimates for restricted activity
days are based on only a few older U.S.-based studies (Ostro, 1987).
It is worth noting, though, that the overall impacts are substantially
driven by effects on mortality, thus the most reliable health effect
estimates. Nonetheless, a recent study adopting different causal
modeling approaches suggests that the currently used relative risks
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may  underestimate the air pollution risk for mortality, reporting
much larger effects on loss in life expectancy (Schwartz, 2016).
Further, the health outcomes assessed in this study are based on
research published in the past years, whereas most recent ﬁndings
are not yet considered. For example, evidence of a causal role of
air pollution in the development of metabolic syndrome (Eze et al.,
2015) and diabetes is not only supported by the Swiss SAPALDIA
study (Eze et al., 2014) but also conﬁrmed by a systematic review
and meta-analysis (Eze et al., 2015) or the above mentioned review
on asthma onset in relation to air pollution. These and other health
outcomes have not been considered in the assessment of this study,
which, thus, must be interpreted a conservative quantiﬁcation of
only the minimal beneﬁts of the Plan OPair 05. Our primary reason
to not expand the assessment was the importance and relevance
for the local authorities to keep this assessment fully comparable
with the recent Swiss National assessment (ECOPLAN and INFRAS,
2014).
This study applies three different types of monetization includ-
ing medical costs, production costs, and immaterial costs. Although
in theory these are additive, it is important to keep in mind that
immaterial costs are very different in nature compared e.g. to health
care costs based on actual hospital spending. Furthermore, imma-
terial costs dominate the total prevented costs, and thus the value
assigned to immaterial costs is very inﬂuential. Variation in VSL is
considerable across studies and populations (OECD, 2012). The VSL
value of CHF 3.3 million used here is the same as in ECOPLAN and
INFRAS (2014). This value is considerably lower than that suggested
by a major meta-analysis conducted by OECD (2012). According to
the WHO’s Health Economic Assessment Tools (HEAT) for walk-
ing and cycling, this would put the VSL for Switzerland at CHF 8.9
million, after adjustment for purchasing power (WHO, 2016b).
Concerning the interpretation of the ﬁndings of this study
it should be noted that the health impacts estimations are
attributable to the reduction of air pollution from 2005 to 2015.
However, to what extent these reductions could be attributed to
the Plan OPair 05 alone remains unknown and was outside of the
scope of this work. Additional local and regional factors not affected
by the Plan OPair 05 may  have contributed to changes in air qual-
ity as well. Second, ALM air quality may  also have beneﬁted from
the adoption of clean air policies in neighboring cities, counties
and indeed in Europe, such as major reductions of exhaust-related
pollutants due to revised European emission standards (Euro V).
Moreover, to comprehensively assess impacts attributable to Plan
OPair 05 per se, one would need to consider its beneﬁcial effects
on air quality in the region at large, and the lag in effects of poli-
cies, which may  yet to result in further reductions in air pollution.
It should also be emphasized that the reference year (2005) does
not indicated the beginning of clean air policies in the ALM. Indeed,
air quality was much worse in the 1980s and 1990s and the related
beneﬁts are all due to local, national, and international clean air
policies.
This study points to a number of ways in which future research
may  contribute to the improvement of similar health impact assess-
ments, as discussed below.
Robust assessments of the effectiveness of speciﬁc clean air
policies in terms of their effects on emissions and ambient concen-
trations remain a key research need to inform future policy making
locally and nationally or internationally. Intermediate factors, such
as changes in vehicle ﬂeet and travel behavior may  serve as proxies
for such evaluations.
To better understand and judge the value of clean air − and
other − policies it is desirable to expand the scope of health impact
studies to include other risk factors and physiological pathways.
A textbook example are transport policies aiming to shift car trips
towards more sustainable modes of transport, which can improve
public health not only in terms of improvements of air quality but
simultaneously by increasing physical activity, and reducing injury
risks or exposure to noise (Mueller et al., 2017; Schepers, 2012).
Such assessments will provide an excellent basis for the evidence
based allocation of public resources and for maximizing synergies
between possibly interrelated policies. For example, speed reduc-
tions of trafﬁc may  reduce air pollution, noise, and accidents.
Further insights could be gained from direct comparisons of
health impact assessments between related or even competing
policy frameworks, possibly including cost-effectiveness analyses
(Brown et al., 2016; Cecchini et al., 2010; Tengs et al., 1995). How-
ever, challenges of harmonizing assessment methods, data, and
in particular cost estimates for policies across domains as diverse
as occupational hazards, public smoking policies, trafﬁc safety or
urban planning remain substantial.
Finally, the development of user-friendly tools for health
impact assessment, similar to for instance HEAT with regards to
active mobility (WHO, 2014b), could be considered to facilitate
more routine-uptake of quantitative health impact assessments to
inform policy-making.
5. Conclusions
The health impacts attributable to a reported reduction of air
pollution from 2005 to 2015 were estimated and monetized at the
regional scale of the ALM. Considering various assumptions and
limitations of this assessment, and given the continued increase in
evidence revealing additional adverse effects of air pollution, the
results of this study are likely reﬂecting a conservative underes-
timation of the total beneﬁts attributable to the improvement of
air quality seen in the ALM during the implementation of the Plan
OPair 05.
While the assessment based on PM10 allowed including a
broader range of health outcomes, overall impacts based on NO2
were considerably larger, possibly capturing more speciﬁcally the
impact of the Plan OPair 05 on local transport related emissions
whereas improvements in PM10 are more substantially a conse-
quence of regional and national policies.
Assessments of health impacts as the one carried out in the
present study help informing decision makers in public administra-
tions to evaluate or predict the success of concrete regional clean
air policy such as the Plan OPair 05. Future efforts should aim at
widening the scope of such assessments in terms of considered
health pathways and related policies. The applied methodology
could also be integrated in user-friendly tools that facilitate routine
applications.
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